Literature DB >> 19172337

Is there a correlation between venlafaxine therapy during pregnancy and a higher incidence of necrotizing enterocolitis?

Markus Treichel1, Katharina Schwendener Scholl, Ulf Kessler, Alexander Joeris, Mathias Nelle.   

Abstract

BACKGROUND: Novel antidepressant drugs are increasingly used by women of child bearing age. However, potentially harmful effects on fetus and newborn remain unknown.
METHODS: Case report and literature review.
RESULTS: We present preterm twins whose mother was treated with venlafaxine, a nonselective serotonin reuptake inhibitor, throughout pregnancy until delivery. The twins developed neonatal necrotizing enterocolitis.
CONCLUSION: The question whether there might be a correlation between maternal serotonin reuptake inhibitor therapy and neonatal necrotizing enterocolitis is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172337     DOI: 10.1007/s12519-009-0013-6

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  11 in total

1.  Neonatal paroxetine withdrawal syndrome.

Authors:  J A Stiskal; N Kulin; G Koren; T Ho; S Ito
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

2.  Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.

Authors:  A Einarson; B Fatoye; M Sarkar; S V Lavigne; J Brochu; C Chambers; P Mastroiacovo; A Addis; D Matsui; L Schuler; T R Einarson; G Koren
Journal:  Am J Psychiatry       Date:  2001-10       Impact factor: 18.112

3.  [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].

Authors:  R A de Moor; L Mourad; J ter Haar; A C Egberts
Journal:  Ned Tijdschr Geneeskd       Date:  2003-07-12

Review 4.  The central role of PAF in necrotizing enterocolitis development.

Authors:  K Muguruma; P W Gray; L W Tjoelker; J M Johnston
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

5.  Perinatal outcome following third trimester exposure to paroxetine.

Authors:  Adriana Moldovan Costei; Eran Kozer; Tommy Ho; Shinya Ito; Gideon Koren
Journal:  Arch Pediatr Adolesc Med       Date:  2002-11

Review 6.  Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.

Authors:  G V Nair; P A Gurbel; C M O'Connor; W A Gattis; S R Murugesan; V L Serebruany
Journal:  Am J Cardiol       Date:  1999-08-01       Impact factor: 2.778

7.  Venlafaxine-associated interstitial pneumonitis.

Authors:  Rachel C Turner; Jeffery E Nelson; Bruce T Roberts; David M Gillam
Journal:  Pharmacotherapy       Date:  2005-04       Impact factor: 4.705

8.  Venlafaxine and asthma.

Authors:  Øyvind Melien; Tone Skaali; Kirsten Myhr; Odd Brørs
Journal:  Nord J Psychiatry       Date:  2005       Impact factor: 2.202

9.  Maternal cocaine abuse: the spectrum of radiologic abnormalities in the neonatal CNS.

Authors:  L A Heier; C R Carpanzano; J Mast; P W Brill; P Winchester; M D Deck
Journal:  AJNR Am J Neuroradiol       Date:  1991 Sep-Oct       Impact factor: 3.825

10.  Time of onset of necrotizing enterocolitis in newborn infants with known prenatal cocaine exposure.

Authors:  S L Lopez; H W Taeusch; R D Findlay; F J Walther
Journal:  Clin Pediatr (Phila)       Date:  1995-08       Impact factor: 1.168

View more
  1 in total

1.  Antenatal Escitalopram Use and Necrotizing Enterocolitis in a Newborn: A Case Report.

Authors:  Nilima Jawale; Alok Bhutada; Shantanu Rastogi
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Nov-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.